Abstract
Expression of the PIP/GCDFP-15 gene was determined by measuring PIP/GCDFP-15-mRNA in breast carcinomas of 91 patients. The patients were followed-up for an average of 47 months after initial diagnosis and treatment of the disease. There were no deaths in the group of 14 patients with tumours of high PIP/GCDFP-15-mRNA levels, while 16 of 77 patients of the group with low PIP/GCDFP-15-mRNA tumour levels died. A similar advantage for high PIP/GCDFP-mRNA expression was observed with regard to disease free survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bundred NJ, Stewart HJ, Shaw DA, Forrest APM, Miller WR (1990) Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Eur J Cancer 26:1145–1147
Byrne MJ, Jamrozik K, Parsons RW, Fitzgerald CJ, Dewar JM, Harvey JM, Sterrett GF, Ingram DM, Sheiner HJ, Cameron FG, Cassidy B (1989) Breast cancer in Western Australia. II. Diagnosis and primary management. Aust J Surg 63:624–629
Hähnel R, Woodings T, Vivian AB (1979) Prognostic value of estrogen receptors in primary breast cancer. Cancer 44:671–675
Hähnel E, Harvey J, Robbins P, Sterrett G, Hähnel R (1994) Hormone regulated genes (pS2, PIP, FAS) in breast cancer and nontumoral mammary tissue. Pathobiology 62:82–89
Le Doussal V, Zangerle P, Colette J, Spyratos F, Hacene K, Briere M, Franchimont P, Gest J (1985) Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15000. Cancer Clin Oncol 21:715–725
Mazoujian G, Pinkus GS, Davis S, Haagensen DE (1983) Immunohistochemistry of a gross cystic disease protein (GCDFP-15) of the breast. Am J Pathol 110:105–112
Mazoujian G, Bodian C, Haagensen DE, Haagensen CD (1989) Expression of GCDFP-15 in breast carcinomas. Cancer 63:2156–2161
Murphy LC, Lee-Wing M, Goldenberg GJ, Shiu RPC (1987) Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res 47:4160–4164
Myal Y, Robinson DB, Iwasiow B, Tsuyuki D, Wong P, Shiu RP (1991) The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol Cell Endocrinol 80:165–175
Pagani A, Sapino A, Eusebi V, Bergnolo P, Bussolati G (1994) PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 425:459–465
Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT (1989) Gross cystic disease fluid protein-15 as a marker for breast cancer. Hum Pathol 20:281–287
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hähnel, R., Hähnel, E. Expression of the PIP/GCDFP-15 gene and survival in breast cancer. Vichows Archiv A Pathol Anat 429, 362–369 (1996). https://doi.org/10.1007/BF00198441
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00198441